A great source of non-dilutive funding for small business concerns (SBCs) and Universities is the Congressionally Directed Medical Research Program (CDMRP summary). CDMRP currently has 32 research programs, which includes the Peer Reviewed Medical Research Program (PRMRP). There are also 50 topic areas in the PRMRP that your company can apply for in FY19. These topics are selected ...
Continue Reading →
The Congressionally Directed Medical Research Programs (CDMRP) offer a great way for small biomedical research companies that are unfamiliar with the Department of Defense (DoD)-associated funding opportunities and application processes to ease into broadening their funding sources to include DoD resources. CDMRP is a congressionally funded special interest set of programs that are managed by the DoD. The CDMRP fills research gaps by funding high impact, high risk, and ...
Continue Reading →
Previously we wrote about Biomedical and Line (non-medical) Department of Defense (DoD) Technology Readiness Levels (TRLs) and medical countermeasure (MCM) TRLs and discussed how a technology may develop through each TRL stage. Here, we will provide additional details on how biomedical TRLs apply specifically to early discovery and development (i.e., TRLs 1-3) drug, biologic or vaccine decision points for new chemical entities (NCE).
DoD biomedical-related technologies require TRL definitions ...
Continue Reading →
Previously, we briefly introduced Biomedical and Line DoD Technology Readiness Levels (TRLs) and discussed how a technology may develop through each stage of the TRL scale. Biomedical TRLs can be further categorized into TRLs for pharmaceuticals (drugs, biologics, and vaccines), medical devices, medical information management/information technology (IM/IT) and medical countermeasures (MCMs) following the FDA Guidance on Product Development under the Animal Rule. In this article, we will focus on biomedical DoD TRLs for medical devices.
The Department of Defense (DoD) and other military assisting Federal Agencies have a large and diverse community of subject matter experts (SME) who are eager to collaborate with industry and universities. These extraordinary SMEs are driven to accelerate new and novel dual-use technologies forward to clinical and operational settings. There are thousands of healthcare providers in 167 DoD medical treatment facilities within the U.S. (59 Navy MTFs); tens of thousands of researchers in the
Continue Reading →
Technology readiness assessments (TRA) are widely utilized by the U.S. Department of Defense (DoD) to determine a technology’s readiness for use in acquisition programs and projects (see the U.S. Government Accountability Office’s Technology Readiness Assessment Guide). The TRA frequently uses a maturity scale – technology readiness levels (TRLs) – that are ordered according to the characteristics of the demonstration or testing environment under which a given technology was tested at defined points in time. ...
Continue Reading →
Does your company have a therapeutic candidate (small molecule, monoclonal antibody, combination product, or other) for the treatment of a type of cancer? Does your therapeutic candidate have multiple indications for multiple types of cancers (e.g., drugs targeting reactive oxygen species [ROS] or cell surface receptors [GPCRs, EGFR]; protein inhibitors [Hsp90, ATR kinase]; epigenetic enzymes [LSD1]; or combination therapies [erlotinib ...
Continue Reading →
The Department of Defense (DoD) and other military assisting Federal Agencies have a large and diverse community of subject matter experts (SME) who are eager to collaborate with industry and universities. These extraordinary SMEs are driven to accelerate new and novel dual-use technologies forward to clinical and operational settings. There are thousands of healthcare providers in 167 DoD medical treatment facilities within the U.S. (43 Army MTFs); tens of thousands of researchers in the
Continue Reading →
The Department of Defense (DoD) and other military assisting Federal Agencies have a large and diverse community of subject matter experts (SME) who are eager to collaborate with industry and universities. These extraordinary SMEs are driven to accelerate new and novel dual-use technologies forward to clinical and operational settings. There are thousands of healthcare providers in 167 DoD medical treatment facilities within the U.S. (63 Air Force MTFs); tens of thousands of researchers in the ...
Continue Reading →
The Medical Technology Enterprise Consortium (MTEC) was established as an enterprise partnership to facilitate research in and translation of life science technologies. MTEC was formed in response to the U.S. Government’s appeal to speed delivery of medical technology that protects, treats, and optimizes the health and performance of U.S. military personnel. The goal of this Consortium is to “conduct research and development activities that advance the state-of-the-art as well as medical science ...
Continue Reading →